目次

Table of Contents

1 Introduction
1.1. What is this report about?
1.2. Who is the target reader?
1.3. How to use this report
1.4. Definitions

2 Top 5 Emerging Countries Generics
2.1. Industry Outlook

3 Generics in South Africa
3.1. Market Overview
3.2. Market Data
3.3. Market Segmentation
3.4. Market outlook
3.5. Five forces analysis

4 Macroeconomic Indicators
4.1. Country data

5 Generics in Brazil
5.1. Market Overview
5.2. Market Data
5.3. Market Segmentation
5.4. Market outlook
5.5. Five forces analysis

6 Macroeconomic Indicators
6.1. Country data

7 Generics in China
7.1. Market Overview
7.2. Market Data
7.3. Market Segmentation
7.4. Market outlook
7.5. Five forces analysis

8 Macroeconomic Indicators
8.1. Country data

9 Generics in India
9.1. Market Overview
9.2. Market Data
9.3. Market Segmentation
9.4. Market outlook
9.5. Five forces analysis

10 Macroeconomic Indicators
10.1. Country data

11 Generics in Mexico
11.1. Market Overview
11.2. Market Data
11.3. Market Segmentation
11.4. Market outlook
11.5. Five forces analysis

12 Macroeconomic Indicators
12.1. Country data

13 Company Profiles
13.1. Teva Pharmaceutical Industries Ltd
13.2. Viatris Inc
13.3. Sun Pharmaceutical Industries Ltd
13.4. Novartis AG
13.5. Sandoz Group AG
13.6. Hikma Pharmaceuticals Plc
13.7. Sanofi
13.8. Les Laboratoires Servier SAS
13.9. Stada Arzneimittel AG
13.10. Bayer AG
13.11. Lupin Ltd
13.12. Aspen Pharmacare Holdings Ltd
13.13. EMS SA
13.14. Eurofarma Laboratorios SA
13.15. Ache Laboratorios Farmaceuticos SA
13.16. Apotex Inc
13.17. Teva Canada Ltd
13.18. Sandoz Canada Inc
13.19. CSPC Pharmaceutical Group Ltd
13.20. Sino Biopharmaceutical Ltd
13.21. Hansoh Pharmaceutical Group Co Ltd
13.22. Dr. Reddy's Laboratories Ltd
13.23. Cipla Ltd
13.24. Aurobindo Pharma Ltd
13.25. PT Kalbe Farma Tbk
13.26. PT Indofarma Tbk
13.27. PT Sanbe Farma
13.28. PT Soho Global Health Tbk
13.29. Friulchem SpA
13.30. DOC Generici SRL
13.31. Recordati SpA
13.32. Daiichi Sankyo Co Ltd
13.33. Towa Pharmaceutical Co Ltd
13.34. Sawai Group Holdings Co Ltd
13.35. Toho Holdings Co Ltd
13.36. Laboratorios Silanes SA de CV
13.37. Pfizer Inc
13.38. Biocad
13.39. R-Pharm
13.40. Pharmstandard
13.41. AstraZeneca Plc
13.42. Bluefish Pharmaceuticals AB
13.43. Navamedic ASA
13.44. Novartis International AG
13.45. Beacons Pharmaceuticals Pte Ltd
13.46. Abbott Laboratories SA
13.47. Adcock Ingram Holdings Ltd
13.48. Dongkook Pharmaceutical Co Ltd
13.49. JW Holdings Corp
13.50. Hanmi Pharmaceuticals Co Ltd
13.51. Dong Wha Pharma Co Ltd
13.52. Esteve Pharmaceuticals SA
13.53. Abdi Ibrahim Ilac Sanayi ve Ticaret AS
13.54. Deva Holding AS
13.55. Sandoz Inc

14 Appendix
14.1. Methodology
14.2. About MarketLine

List of Tables
Table 1: Top 5 emerging countries generics industry, revenue ($m), 2019-28
Table 2: Top 5 emerging countries generics industry, revenue ($m), 2019-23
Table 3: Top 5 emerging countries generics industry forecast, revenue ($m), 2023-28
Table 4: South Africa generics market value: $ million, 2018-23
Table 5: South Africa generics market volume: % of total pharma volume, 2018-23
Table 6: South Africa generics market geography segmentation: $ million, 2023
Table 7: South Africa generics market value forecast: $ million, 2023-28
Table 8: South Africa generics market volume forecast: % of total pharma volume, 2023-28
Table 9: South Africa Size of Population (million), 2019-23
Table 10: South Africa real GDP (Constant 2010 Prices, $ billion), 2019-23
Table 11: South Africa GDP (Current Prices, $ Billion), 2019-23
Table 12: South Africa Inflation, 2019-23
Table 13: South Africa Consumer Price Index (Absolute), 2019-23
Table 14: South Africa exchange rate, 2018-23
Table 15: Brazil generics market value: $ million, 2018-23
Table 16: Brazil generics market volume: % of total pharma volume, 2018-23
Table 17: Brazil generics market geography segmentation: $ million, 2023
Table 18: Brazil generics market value forecast: $ million, 2023-28
Table 19: Brazil generics market volume forecast: % of total pharma volume, 2023-28
Table 20: Brazil Size of Population (million), 2019-23
Table 21: Brazil real GDP (Constant 2010 Prices, $ billion), 2019-23
Table 22: Brazil GDP (Current Prices, $ Billion), 2019-23
Table 23: Brazil Inflation, 2019-23
Table 24: Brazil Consumer Price Index (Absolute), 2019-23
Table 25: Brazil exchange rate, 2018-23
Table 26: China generics market value: $ million, 2018-23
Table 27: China generics market volume: % of total pharma volume, 2018-23
Table 28: China generics market geography segmentation: $ million, 2023
Table 29: China generics market value forecast: $ million, 2023-28
Table 30: China generics market volume forecast: % of total pharma volume, 2023-28
Table 31: China Size of Population (million), 2019-23
Table 32: China real GDP (Constant 2010 Prices, $ billion), 2019-23
Table 33: China GDP (Current Prices, $ Billion), 2019-23
Table 34: China Inflation, 2019-23
Table 35: China Consumer Price Index (Absolute), 2019-23
Table 36: China exchange rate, 2018-23
Table 37: India generics market value: $ million, 2018-23
Table 38: India generics market volume: % of total pharma volume, 2018-23
Table 39: India generics market geography segmentation: $ million, 2023
Table 40: India generics market value forecast: $ million, 2023-28
Table 41: India generics market volume forecast: % of total pharma volume, 2023-28
Table 42: India Size of Population (million), 2019-23
Table 43: India real GDP (Constant 2010 Prices, $ billion), 2019-23
Table 44: India GDP (Current Prices, $ Billion), 2019-23
Table 45: India Inflation, 2019-23
Table 46: India Consumer Price Index (Absolute), 2019-23
Table 47: India exchange rate, 2018-23
Table 48: Mexico generics market value: $ million, 2018-23
Table 49: Mexico generics market volume: % of total pharma volume, 2018-23
Table 50: Mexico generics market geography segmentation: $ million, 2023
Table 51: Mexico generics market value forecast: $ million, 2023-28
Table 52: Mexico generics market volume forecast: % of total pharma volume, 2023-28
Table 53: Mexico Size of Population (million), 2019-23
Table 54: Mexico real GDP (Constant 2010 Prices, $ billion), 2019-23
Table 55: Mexico GDP (Current Prices, $ Billion), 2019-23
Table 56: Mexico Inflation, 2019-23
Table 57: Mexico Consumer Price Index (Absolute), 2019-23
Table 58: Mexico exchange rate, 2018-23
Table 59: Teva Pharmaceutical Industries Ltd: key facts
Table 60: Teva Pharmaceutical Industries Ltd: Annual Financial Ratios
Table 61: Teva Pharmaceutical Industries Ltd: Key Employees
Table 62: Viatris Inc: key facts
Table 63: Viatris Inc: Annual Financial Ratios
Table 64: Viatris Inc: Key Employees
Table 65: Sun Pharmaceutical Industries Ltd: key facts
Table 66: Sun Pharmaceutical Industries Ltd: Annual Financial Ratios
Table 67: Sun Pharmaceutical Industries Ltd: Key Employees
Table 68: Novartis AG: key facts
Table 69: Novartis AG: Annual Financial Ratios
Table 70: Novartis AG: Key Employees
Table 71: Sandoz Group AG: key facts
Table 72: Sandoz Group AG: Key Employees
Table 73: Hikma Pharmaceuticals Plc: key facts
Table 74: Hikma Pharmaceuticals Plc: Annual Financial Ratios
Table 75: Hikma Pharmaceuticals Plc: Key Employees
Table 76: Sanofi: key facts
Table 77: Sanofi: Annual Financial Ratios
Table 78: Sanofi: Key Employees
Table 79: Les Laboratoires Servier SAS: key facts
Table 80: Les Laboratoires Servier SAS: Key Employees
Table 81: Stada Arzneimittel AG: key facts
Table 82: Stada Arzneimittel AG: Key Employees
Table 83: Bayer AG: key facts
Table 84: Bayer AG: Annual Financial Ratios
Table 85: Bayer AG: Key Employees
Table 86: Bayer AG: Key Employees Continued
Table 87: Bayer AG: Key Employees Continued
Table 88: Lupin Ltd: key facts
Table 89: Lupin Ltd: Annual Financial Ratios
Table 90: Lupin Ltd: Key Employees
Table 91: Aspen Pharmacare Holdings Ltd: key facts
Table 92: Aspen Pharmacare Holdings Ltd: Annual Financial Ratios
Table 93: Aspen Pharmacare Holdings Ltd: Key Employees
Table 94: EMS SA: key facts
Table 95: EMS SA: Key Employees
Table 96: Eurofarma Laboratorios SA: key facts
Table 97: Eurofarma Laboratorios SA: Key Employees
Table 98: Ache Laboratorios Farmaceuticos SA: key facts
Table 99: Ache Laboratorios Farmaceuticos SA: Key Employees

List of Figures
Figure 1: Top 5 emerging countries generics industry, revenue ($m), 2019-28
Figure 2: Top 5 emerging countries generics industry, revenue ($m), 2019-23
Figure 3: Top 5 emerging countries generics industry forecast, revenue ($m), 2023-28
Figure 4: South Africa generics market value: $ million, 2018-23
Figure 5: South Africa generics market volume: % of total pharma volume, 2018-23
Figure 6: South Africa generics market geography segmentation: % share, by value, 2023
Figure 7: South Africa generics market value forecast: $ million, 2023-28
Figure 8: South Africa generics market volume forecast: % of total pharma volume, 2023-28
Figure 9: Forces driving competition in the generics market in South Africa, 2023
Figure 10: Drivers of buyer power in the generics market in South Africa, 2023
Figure 11: Drivers of supplier power in the generics market in South Africa, 2023
Figure 12: Factors influencing the likelihood of new entrants in the generics market in South Africa, 2023
Figure 13: Factors influencing the threat of substitutes in the generics market in South Africa, 2023
Figure 14: Drivers of degree of rivalry in the generics market in South Africa, 2023
Figure 15: Brazil generics market value: $ million, 2018-23
Figure 16: Brazil generics market volume: % of total pharma volume, 2018-23
Figure 17: Brazil generics market geography segmentation: % share, by value, 2023
Figure 18: Brazil generics market value forecast: $ million, 2023-28
Figure 19: Brazil generics market volume forecast: % of total pharma volume, 2023-28
Figure 20: Forces driving competition in the generics market in Brazil, 2023
Figure 21: Drivers of buyer power in the generics market in Brazil, 2023
Figure 22: Drivers of supplier power in the generics market in Brazil, 2023
Figure 23: Factors influencing the likelihood of new entrants in the generics market in Brazil, 2023
Figure 24: Factors influencing the threat of substitutes in the generics market in Brazil, 2023
Figure 25: Drivers of degree of rivalry in the generics market in Brazil, 2023
Figure 26: China generics market value: $ million, 2018-23
Figure 27: China generics market volume: % of total pharma volume, 2018-23
Figure 28: China generics market geography segmentation: % share, by value, 2023
Figure 29: China generics market value forecast: $ million, 2023-28
Figure 30: China generics market volume forecast: % of total pharma volume, 2023-28
Figure 31: Forces driving competition in the generics market in China, 2023
Figure 32: Drivers of buyer power in the generics market in China, 2023
Figure 33: Drivers of supplier power in the generics market in China, 2023
Figure 34: Factors influencing the likelihood of new entrants in the generics market in China, 2023
Figure 35: Factors influencing the threat of substitutes in the generics market in China, 2023
Figure 36: Drivers of degree of rivalry in the generics market in China, 2023
Figure 37: India generics market value: $ million, 2018-23
Figure 38: India generics market volume: % of total pharma volume, 2018-23
Figure 39: India generics market geography segmentation: % share, by value, 2023
Figure 40: India generics market value forecast: $ million, 2023-28
Figure 41: India generics market volume forecast: % of total pharma volume, 2023-28
Figure 42: Forces driving competition in the generics market in India, 2023
Figure 43: Drivers of buyer power in the generics market in India, 2023
Figure 44: Drivers of supplier power in the generics market in India, 2023
Figure 45: Factors influencing the likelihood of new entrants in the generics market in India, 2023
Figure 46: Factors influencing the threat of substitutes in the generics market in India, 2023
Figure 47: Drivers of degree of rivalry in the generics market in India, 2023
Figure 48: Mexico generics market value: $ million, 2018-23
Figure 49: Mexico generics market volume: % of total pharma volume, 2018-23
Figure 50: Mexico generics market geography segmentation: % share, by value, 2023
Figure 51: Mexico generics market value forecast: $ million, 2023-28
Figure 52: Mexico generics market volume forecast: % of total pharma volume, 2023-28
Figure 53: Forces driving competition in the generics market in Mexico, 2023
Figure 54: Drivers of buyer power in the generics market in Mexico, 2023
Figure 55: Drivers of supplier power in the generics market in Mexico, 2023
Figure 56: Factors influencing the likelihood of new entrants in the generics market in Mexico, 2023
Figure 57: Factors influencing the threat of substitutes in the generics market in Mexico, 2023
Figure 58: Drivers of degree of rivalry in the generics market in Mexico, 2023